On the relationship between docking scores and protein conformational changes in HIV-1 protease
-
Add time:09/06/2019 Source:sciencedirect.com
We present a detailed investigation of the effect of the crystallographic structure of the HIV-1 protease (PR) on the binding energy of different classes of inhibitors obtained from docking simulations. The crystal structures of 222 HIV-1 proteases (in wild-type and mutant forms) and 202 inhibitors were downloaded from appropriate databases. A cross-docking approach (docking of all 202 inhibitors to all 222 PR structures) using Autodock Vina was implemented. The protease structures were clustered using a Kohonen self-organization map analysis of the data matrix of docking energies. The obtained clusters of PRs were correlated with the x-y-z coordinates of the PR structures to identify structural segments underlying this clustering. The PR structures were clustered into 4 classes. One of these classes exhibits rather strong binding with almost all inhibitors, while another class exhibits rather weak binding. The remaining two classes are intermediate in binding strength. The selectivity ratio indices for the carbon-alpha atoms of the PR structures indicate that conformational motion of residues outside the binding pocket contributes significantly to the discrimination of the 4 classes.
We also recommend Trading Suppliers and Manufacturers of HIV PROTEASE SUBSTRATE III (cas 138608-20-5). Pls Click Website Link as below: cas 138608-20-5 suppliers
Prev:Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay
Next:HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationYeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study09/26/2019
- Expedient screening for HIV-1 protease inhibitors using a simplified immunochromatographic assay09/25/2019
- Review articleDesign strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties09/24/2019
- Research paperEvolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis09/10/2019
- Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes09/09/2019
- A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening09/08/2019
- HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies09/07/2019
- Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay09/05/2019
- Research paperHIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance09/04/2019


